Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott MacDonald

Showing results (121-130 of 137) with videos related to

Pageof 14
Sort By:
Substance Abuse Treatment, Prevention, and Policy|September 17, 2021
Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatmentHeather Palis, Kirsten Marchand, Gerald Spike Peachey, et al.
Addictive Behaviors Reports|June 13, 2018
The association between nicotine dependence and physical health among people receiving injectable diacetylmorphine or hydromorphone for the treatment of chronic opioid use disorderHeather Palis, Kirsten Marchand, Mohammad Karamouzian, et al.
Addiction (Abingdon, England)|May 21, 2019
Cannabis use as a risk factor for causing motor vehicle crashes: a prospective studyJeffrey R Brubacher, Herbert Chan, Shannon Erdelyi, et al.
JAMA Internal Medicine|September 8, 2018
Effect of Mobile Device-Supported Single-Patient Multi-crossover Trials on Treatment of Chronic Musculoskeletal Pain: A Randomized Clinical TrialRichard L Kravitz, Christopher H Schmid, Maria Marois, et al.
Drug and Alcohol Dependence|May 19, 2017
Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorderEugenia Oviedo-Joekes, Suzanne Brissette, Scott MacDonald, et al.
Nature Communications|October 29, 2014
Loss of beta2-integrin-mediated cytoskeletal linkage reprogrammes dendritic cells to a mature migratory phenotypeVicky Louise Morrison, Martyn John James, Katarzyna Grzes, et al.
Annals of Internal Medicine|March 4, 2024
Quality Indicators for Major Depressive Disorder in Adults: A Review of Performance Measures by the American College of PhysiciansAmir Qaseem, Rebecca A Andrews, Karen Campos, et al.
JAMA Network Open|March 20, 2023
Perspectives of Patients About Immediate Access to Test Results Through an Online Patient PortalBryan D Steitz, Robert W Turer, Chen-Tan Lin, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|June 10, 2026
Alternative models of consent in out-of-hospital transfusion trials: a CAN-PATT position statement supporting exception from prospective consent with opt-out notificationMichael Peddle, Adam Greene, Jan Trojanowski, et al.
JCI Insight|December 17, 2020
Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria preventionNeville K Kisalu, Lais D Pereira, Keenan Ernste, et al.
Pageof 14

Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
Substance Abuse Treatment, Prevention, and Policy|September 17, 2021
Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatmentHeather Palis, Kirsten Marchand, Gerald Spike Peachey, et al.
Addictive Behaviors Reports|June 13, 2018
The association between nicotine dependence and physical health among people receiving injectable diacetylmorphine or hydromorphone for the treatment of chronic opioid use disorderHeather Palis, Kirsten Marchand, Mohammad Karamouzian, et al.
Addiction (Abingdon, England)|May 21, 2019
Cannabis use as a risk factor for causing motor vehicle crashes: a prospective studyJeffrey R Brubacher, Herbert Chan, Shannon Erdelyi, et al.
JAMA Internal Medicine|September 8, 2018
Effect of Mobile Device-Supported Single-Patient Multi-crossover Trials on Treatment of Chronic Musculoskeletal Pain: A Randomized Clinical TrialRichard L Kravitz, Christopher H Schmid, Maria Marois, et al.
Drug and Alcohol Dependence|May 19, 2017
Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorderEugenia Oviedo-Joekes, Suzanne Brissette, Scott MacDonald, et al.
Nature Communications|October 29, 2014
Loss of beta2-integrin-mediated cytoskeletal linkage reprogrammes dendritic cells to a mature migratory phenotypeVicky Louise Morrison, Martyn John James, Katarzyna Grzes, et al.
Annals of Internal Medicine|March 4, 2024
Quality Indicators for Major Depressive Disorder in Adults: A Review of Performance Measures by the American College of PhysiciansAmir Qaseem, Rebecca A Andrews, Karen Campos, et al.
JAMA Network Open|March 20, 2023
Perspectives of Patients About Immediate Access to Test Results Through an Online Patient PortalBryan D Steitz, Robert W Turer, Chen-Tan Lin, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|June 10, 2026
Alternative models of consent in out-of-hospital transfusion trials: a CAN-PATT position statement supporting exception from prospective consent with opt-out notificationMichael Peddle, Adam Greene, Jan Trojanowski, et al.
JCI Insight|December 17, 2020
Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria preventionNeville K Kisalu, Lais D Pereira, Keenan Ernste, et al.
Pageof 14